These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 12209974

  • 1. Cyclosporin A enhances the apoptotic effects of N-(4-hydroxyphenyl)retinamide in breast cancer cells.
    Lim SJ, Simeone AM, Kim CK, Tari AM.
    Int J Cancer; 2002 Sep 20; 101(3):243-7. PubMed ID: 12209974
    [Abstract] [Full Text] [Related]

  • 2. Higher potency of N-(4-hydroxyphenyl)retinamide than all-trans-retinoic acid in induction of apoptosis in non-small cell lung cancer cell lines.
    Zou CP, Kurie JM, Lotan D, Zou CC, Hong WK, Lotan R.
    Clin Cancer Res; 1998 May 20; 4(5):1345-55. PubMed ID: 9607596
    [Abstract] [Full Text] [Related]

  • 3. Upregulation of GADD153 expression in the apoptotic signaling of N-(4-hydroxyphenyl)retinamide (4HPR).
    Xia Y, Wong NS, Fong WF, Tideman H.
    Int J Cancer; 2002 Nov 01; 102(1):7-14. PubMed ID: 12353227
    [Abstract] [Full Text] [Related]

  • 4. N-(4-hydroxyphenyl)-retinamide selectively increases All-TRANS retinoic acid inhibitory effects in HER2/NEU-overexpressing breast cancer cells.
    Lim SJ, Gutiérrez-Puente Y, Tari AM.
    Tumour Biol; 2002 Nov 01; 23(5):279-86. PubMed ID: 12595744
    [Abstract] [Full Text] [Related]

  • 5. Distinct patterns of mitochondrial changes precede induction of apoptosis by all-trans-retinoic acid and N-(4-hydroxyphenyl)retinamide in MCF7 breast cancer cells.
    Poot M, Hosier S, Swisshelm K.
    Exp Cell Res; 2002 Sep 10; 279(1):128-40. PubMed ID: 12213221
    [Abstract] [Full Text] [Related]

  • 6. Effects of novel phenylretinamides on cell growth and apoptosis in bladder cancer.
    Clifford JL, Sabichi AL, Zou C, Yang X, Steele VE, Kelloff GJ, Lotan R, Lippman SM.
    Cancer Epidemiol Biomarkers Prev; 2001 Apr 10; 10(4):391-5. PubMed ID: 11319181
    [Abstract] [Full Text] [Related]

  • 7. Differential induction of apoptosis by all-trans-retinoic acid and N-(4-hydroxyphenyl)retinamide in human head and neck squamous cell carcinoma cell lines.
    Oridate N, Lotan D, Xu XC, Hong WK, Lotan R.
    Clin Cancer Res; 1996 May 10; 2(5):855-63. PubMed ID: 9816241
    [Abstract] [Full Text] [Related]

  • 8. A novel mechanism by which N-(4-hydroxyphenyl)retinamide inhibits breast cancer cell growth: the production of nitric oxide.
    Simeone AM, Ekmekcioglu S, Broemeling LD, Grimm EA, Tari AM.
    Mol Cancer Ther; 2002 Oct 10; 1(12):1009-17. PubMed ID: 12481423
    [Abstract] [Full Text] [Related]

  • 9. Fenretinide stimulates redox-sensitive ceramide production in breast cancer cells: potential role in drug-induced cytotoxicity.
    Rehman F, Shanmugasundaram P, Schrey MP.
    Br J Cancer; 2004 Nov 15; 91(10):1821-8. PubMed ID: 15505623
    [Abstract] [Full Text] [Related]

  • 10. Mitochondrial permeability transition is a central coordinating event in N-(4-hydroxyphenyl)retinamide-induced apoptosis.
    Hail N, Lotan R.
    Cancer Epidemiol Biomarkers Prev; 2000 Dec 15; 9(12):1293-301. PubMed ID: 11142414
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. HER2/neu reduces the apoptotic effects of N-(4-hydroxyphenyl)retinamide (4-HPR) in breast cancer cells by decreasing nitric oxide production.
    Simeone AM, Broemeling LD, Rosenblum J, Tari AM.
    Oncogene; 2003 Oct 02; 22(43):6739-47. PubMed ID: 14555987
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. N-(4-Hydroxyphenyl)retinamide is more potent than other phenylretinamides in inhibiting the growth of BRCA1-mutated breast cancer cells.
    Simeone AM, Deng CX, Kelloff GJ, Steele VE, Johnson MM, Tari AM.
    Carcinogenesis; 2005 May 02; 26(5):1000-7. PubMed ID: 15695235
    [Abstract] [Full Text] [Related]

  • 16. Is growth inhibition and induction of apoptosis in lung cancer cell lines by fenretinide [N-(4-hydroxyphenyl)retinamide] sufficient for cancer therapy?
    Ohlmann CH, Jung C, Jaques G.
    Int J Cancer; 2002 Aug 10; 100(5):520-6. PubMed ID: 12124800
    [Abstract] [Full Text] [Related]

  • 17. Anti-tumor effects of retinoids combined with trastuzumab or tamoxifen in breast cancer cells: induction of apoptosis by retinoid/trastuzumab combinations.
    Koay DC, Zerillo C, Narayan M, Harris LN, DiGiovanna MP.
    Breast Cancer Res; 2010 Aug 10; 12(4):R62. PubMed ID: 20696059
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Different ways to induce apoptosis by fenretinide and all-trans-retinoic acid in human B lymphoma cells.
    Barna G, Sebestyén A, Weischede S, Peták I, Mihalik R, Formelli F, Kopper L.
    Anticancer Res; 2005 Aug 10; 25(6B):4179-85. PubMed ID: 16309214
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.